肝脏炎性肌纤维母细胞瘤诊断及治疗相关进展  

Advances in the Diagnosis and Treatment of Inflammatory Myofibroblastic Tumor of the Liver

作　　者：周徐雷 沈宇杰 邵惠江[2] 

机构地区：[1]绍兴文理学院医学院,浙江 绍兴 [2]绍兴市人民医院肝胆胰外科,浙江 绍兴

出　　处：《临床医学进展》2024年第10期1171-1176,共6页Advances in Clinical Medicine

摘　　要：炎性肌纤维母细胞瘤(Inflammatory Myofibroblastic Tumor, IMT)最常发生于肺脏,发生在肝脏的比较少见,肝脏炎性肌纤维母细胞瘤是一种非常罕见的具有潜在恶性的肿瘤,完全手术切除后的预后较为良好。然而,它缺乏特定的临床症状和独特的影像学特征。同时,肝脏IMT的罕见性不应降低其在肝脏肿瘤鉴别诊断中的重要性。本文就肝脏炎性肌纤维母细胞瘤(IMT)的临床表现、影像学表现、病理组织学表现、鉴别诊断及诊断治疗策略等方面对其进行全面的阐述以及了解。Inflammatory myofibroblastic tumor (IMT) occurs most often in the lungs, but less commonly in the liver, hepatic inflammatory myofibroblastoma is a very rare potentially malignant tumor, and the prognosis after surgical resection is relatively good. However, it lacks specific clinical symptoms and unique imaging features. At the same time, the rarity of hepatic IMT should not diminish its importance in the differential diagnosis of liver tumors. This article provides a comprehensive introduction and understanding of the clinical manifestations, imaging manifestations, histopathological manifestations, differential diagnosis, and diagnostic and therapeutic strategies of inflammatory myofibroblastoma (IMT) in the liver.

关 键 词：炎性肌纤维母细胞瘤 肝脏临床表现 病理组织学 诊断治疗 

分 类 号：R73[医药卫生—肿瘤]